Overview
Edit Porpaczy practices in Vienna, Austria. Ms. Porpaczy is highly rated in 4 conditions, according to our data. Her top areas of expertise are Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), B-Cell Lymphoma, and Non-Hodgkin Lymphoma.
Her clinical research consists of co-authoring 31 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaMs. Porpaczy isAdvanced. Learn about B-Cell Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Ms. Porpaczy isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Porpaczy isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Non-Hodgkin LymphomaMs. Porpaczy isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Cardiomyopathy Due to AnthracyclinesMs. Porpaczy isExperienced. Learn about Cardiomyopathy Due to Anthracyclines.
- Danon DiseaseMs. Porpaczy isExperienced. Learn about Danon Disease.
- Diffuse Large B-Cell Lymphoma (DLBCL)Ms. Porpaczy isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Doxorubicin-Induced CardiomyopathyMs. Porpaczy isExperienced. Learn about Doxorubicin-Induced Cardiomyopathy.
- Hodgkin LymphomaMs. Porpaczy isExperienced. Learn about Hodgkin Lymphoma.
- LeukemiaMs. Porpaczy isExperienced. Learn about Leukemia.